Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Alamo Group
ALG
$2.01B
| $17M | ﹤0.01% |
111,218
+2,850
| +3% | +$442K |
|
1827
Autoliv
ALV
$8.94B
| $16.9M | ﹤0.01% |
173,191
-19,916
| -10% | -$2.01M |
|
|
CIM
1828
Chimera Investment
CIM
$988M
| $16.9M | ﹤0.01% |
374,183
+48,887
| +15% | +$2.03M |
|
1829
Dime Commercial Bancshares
DCOM
$1.81B
| $16.9M | ﹤0.01% |
502,003
-22,965
| -4% | -$772K |
|
|
RETA
1830
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $16.9M | ﹤0.01% |
119,169
+24,079
| +25% | +$2.72M |
|
1831
Rithm Capital
RITM
$5.79B
| $16.9M | ﹤0.01% |
1,592,483
+251,672
| +19% | +$2.67M |
|
|
SAFE
1832
Safehold
SAFE
$1.08B
| $16.9M | ﹤0.01% |
167,133
-8,819
| -5% | -$782K |
|
|
ANAT
1833
DELISTED
American National Group, Inc. Common Stock
ANAT
| $16.8M | ﹤0.01% |
113,395
+10,190
| +10% | +$1.36M |
|
1834
Pathward Financial
CASH
$1.8B
| $16.8M | ﹤0.01% |
332,533
-24,673
| -7% | -$1.22M |
|
1835
Triumph Financial Inc
TFIN
$1.87B
| $16.8M | ﹤0.01% |
225,894
-15,779
| -7% | -$1.34M |
|
|
SJR
1836
DELISTED
Shaw Communications Inc.
SJR
| $16.8M | ﹤0.01% |
579,784
-23,162
| -4% | -$668K |
|
|
GBIO
1837
DELISTED
Generation Bio
GBIO
| $16.7M | ﹤0.01% |
62,207
+5,448
| +10% | +$1.63M |
|
|
ADAM
1838
Adamas Trust
ADAM
$910M
| $16.7M | ﹤0.01% |
935,564
-57,044
| -6% | -$1.04M |
|
1839
Encore Capital Group
ECPG
$2.2B
| $16.7M | ﹤0.01% |
352,454
-21,673
| -6% | -$942K |
|
1840
Schneider National
SNDR
$6.33B
| $16.7M | ﹤0.01% |
765,595
-35,018
| -4% | -$847K |
|
|
AYX
1841
DELISTED
Alteryx Inc
AYX
| $16.6M | ﹤0.01% |
193,505
+24,428
| +14% | +$2M |
|
1842
Matthews International
MATW
$725M
| $16.6M | ﹤0.01% |
462,260
-8,059
| -2% | -$322K |
|
1843
Enerpac Tool Group
EPAC
$1.89B
| $16.6M | ﹤0.01% |
623,649
-39,372
| -6% | -$1.05M |
|
|
FOE
1844
DELISTED
Ferro Corporation
FOE
| $16.6M | ﹤0.01% |
768,413
-508,295
| -40% | -$10M |
|
|
APLS
1845
DELISTED
Apellis Pharmaceuticals
APLS
| $16.6M | ﹤0.01% |
262,028
+34,894
| +15% | +$1.8M |
|
1846
Algonquin Power & Utilities
AQN
$4.53B
| $16.5M | ﹤0.01% |
1,109,615
+175,462
| +19% | +$2.76M |
|
|
BRKL
1847
DELISTED
Brookline Bancorp
BRKL
| $16.5M | ﹤0.01% |
1,103,743
-51,225
| -4% | -$820K |
|
1848
Roblox
RBLX
$27.3B
| $16.5M | ﹤0.01% |
183,344
+57,885
| +46% | +$4.65M |
|
1849
Rush Enterprises Class A
RUSHA
$9.6B
| $16.5M | ﹤0.01% |
572,087
+38,414
| +7% | +$1.23M |
|
|
INOV
1850
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $16.5M | ﹤0.01% |
482,760
+37,399
| +8% | +$1.16M |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.